Two new observational studies suggest GLP-1 receptor agonists, including tirzepatide, may reduce heart failure and other complications after transcatheter aortic valve replacement and carotid artery ...

A risk model allowing cardiologists and their patients to share decision-making about undergoing surgery after transcatheter aortic valve replacement (TAVR) had received high marks for its accuracy in ...

2025 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- A new study on Managed Care is now available. According to news reporting originating in Atlanta, Georgia, by ...

NEW YORK, NY — Nearly 6% of patients undergoing transcatheter aortic-valve replacement (TAVR) will experience a late major bleeding complication, and these bleeding events are associated with a ...

Two new observational studies suggest GLP-1 receptor agonists may reduce cardiovascular risks after transcatheter aortic valve replacement (TAVR) and carotid artery stenting (CAS). Tirzepatide use ...

With protamine routinely given at the end of transcatheter aortic valve replacement or implantation (TAVR or TAVI), patients achieved hemostasis quicker and with greater success, according to the ...

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...

NEW YORK CITY -- Women with severe native aortic stenosis (AS) gained significantly better results from surgery with aortic annular enlargement (AAE) than transcatheter aortic valve replacement (TAVR) ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At 7 years, there was no difference in clinical outcomes ...